Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
2001-5-10
pubmed:abstractText
Population Helicobacter pylori screening and treatment has been advocated as a means of reducing mortality from gastric cancer. The optimum Helicobacter pylori eradication therapy to use in this setting is uncertain.
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Mar
pubmed:issn
1590-8658
pubmed:author
pubmed:issnType
Print
pubmed:volume
33
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
131-4
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:11346140-Adult, pubmed-meshheading:11346140-Amoxicillin, pubmed-meshheading:11346140-Clarithromycin, pubmed-meshheading:11346140-Dose-Response Relationship, Drug, pubmed-meshheading:11346140-Drug Administration Schedule, pubmed-meshheading:11346140-Drug Therapy, Combination, pubmed-meshheading:11346140-Female, pubmed-meshheading:11346140-Follow-Up Studies, pubmed-meshheading:11346140-Helicobacter Infections, pubmed-meshheading:11346140-Helicobacter pylori, pubmed-meshheading:11346140-Humans, pubmed-meshheading:11346140-Logistic Models, pubmed-meshheading:11346140-Male, pubmed-meshheading:11346140-Mass Screening, pubmed-meshheading:11346140-Metronidazole, pubmed-meshheading:11346140-Middle Aged, pubmed-meshheading:11346140-Omeprazole, pubmed-meshheading:11346140-Probability, pubmed-meshheading:11346140-Reference Values, pubmed-meshheading:11346140-Treatment Outcome
pubmed:year
2001
pubmed:articleTitle
Randomised study of the efficacy of omeprazole and clarithromycin with either amoxycillin or metronidazole in the eradication of Helicobacter pylori in screened primary care patients.
pubmed:affiliation
Centre for Digestive Diseases, The General Infirmary at Leeds, UK. pandsnev@globalnet.co.uk
pubmed:publicationType
Journal Article, Clinical Trial, Comparative Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't